Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term "Endoplasmic reticulum stress/NF-kappaB pathway proteins" does not refer to a single molecular target but rather describes two interconnected cellular pathways involving multiple distinct protein families. The endoplasmic reticulum (ER) stress response is mediated by the unfolded protein response (UPR)—a network of sensors including inositol-requiring enzyme 1 alpha (IRE1α), PKR-like ER kinase (PERK), and activating transcription factor 6 (ATF6)—which detect misfolded or unfolded proteins in the ER lumen and initiate adaptive or apoptotic responses[7][2][3]. These sensors regulate downstream effectors such as X-box binding protein 1 (XBP1), ATF4, C/EBP homologous protein (CHOP), and others that modulate cell survival or death depending on the severity of the stress[7][2][3]. The NF-kappaB pathway, meanwhile, is a central regulator of inflammation and immune responses. There is documented crosstalk between UPR/ER-stress signaling branches—particularly IRE1α—and NF-kappaB activation; for example, IRE1 can activate JNK via TRAF2 recruitment which can influence inflammatory gene expression[7][2]. Both pathways are implicated in diseases such as cancer, inflammation-related disorders, neurodegeneration, cardiovascular disease, and more[3][10]. Because this entry refers to an entire set of pathways rather than a specific molecule or receptor/protein target suitable for drug development profiling—and because it combines two broad systems ("ER stress" with "NF-kappaB")—it should be flagged as incorrect for structured target annotation purposes. > "The UPR is regulated by three main proteins: inositol-requiring enzyme 1α (IRE1α), PKR-like ER kinase (PERK) and activating transcription factor 6 (ATF6)... Under ER stress conditions BIP dissociates... This process activates IRE1α and PERK..." [7] > "A crosstalk between IRE1α and TNF signaling has been documented previously... It is conceivable that pro-apoptotic UPR employs at least in part the same pathways as TNF signaling..." [6] In summary: this entry does not correspond to a single canonical therapeutic target but instead references multiple related but distinct molecular entities within complex cellular networks.
Inhibition of IRE1α RNase activity to reduce pro-inflammatory cytokine secretion and cell death[6]
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Endoplasmic reticulum stress and NF-kappaB pathway proteins.